N/A
N=68
A Trial of E-cigarettes in Current Cigarette Smokers
Smoking · Nicotine Dependence · Nicotine Dependence, Other Tobacco Product
Bottom Line
View on ClinicalTrials.gov: NCT02357173 ↗Enrolled (actual)
68
Serious AEs
0.0%
Results posted
Apr 2018
Primary outcome: Primary: Uptake of Electronic Nicotine Delivery Systems (ENDS) — 57.14; 32; 13.64 percentage of participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- electronic cigarette (Other); cigarette group (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Medical University of South Carolina
- Primary completion
- May 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Uptake of Electronic Nicotine Delivery Systems (ENDS) |
57.14; 32; 13.64 | — |
| PRIMARY Independent Purchase of an ENDs Product |
57; 28; 14 | — |
| PRIMARY % Quit Attempts |
47.6; 40; 27.3 | — |
| PRIMARY Point Prevalence Abstinence |
9.5; 4.0; 4.6 | — |
Summary
The purpose of this study is to examine cigarette smokers' use of electronic cigarettes (e-cigarettes), and how use of e-cigarettes affects short term smoking behavior.
Eligibility Criteria
Inclusion Criteria
- age 18+
- current smoker of at least 5 cigarettes per day for at least 1 year
- at least some concern for health effects of smoking
- having an easily accessible email address
Exclusion Criteria
- past six month use of any e-cigarette
- lifetime ever purchase of any e-cigarette
- recent history of cardiovascular distress (heart attack in past year; arrhythmia; uncontrolled hypertension)
- recent history (past 3 months) of Chronic Obstructive Pulmonary Disease (COPD), cancer (any non-dermatologic), or uncontrolled diabetes mellitus
- pregnant or breastfeeding
- any major current psychiatric impairment, including current alcohol/drug abuse/dependence
- use of non-cigarette tobacco products (e.g., cigarillos) in the last 30 days
- current use of any smoking cessation medications
- current enrollment in a smoking cessation treatment study
Data sourced from ClinicalTrials.gov (NCT02357173). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.